[Globe Newswire] Cerner Corporation (NASDAQ:CERN) (TREND ANALYSIS), is once again the top performing enterprise health information exchange (HIE) supplier for inpatient/ambulatory health information technology, according to Black Book Rankings’ 2015 HIE User Survey. This marks the third consecutive year that Cerner has earned the designation.
“Long before interoperability became an industry hot topic, Cerner understood the importance of helping providers connect information across organizational, geographic and technological boundaries,” said Bob Robke, Cerner vice president for interoperability strategies and solutions, and board treasurer for CommonWell Health Alliance. “Our continued high marks from clients in the Black Book HIE user survey demonstrate that Cerner has been able to successfully break through organizational silos to connect information that can benefit providers and patients.”
Stock Performance: Click here for a free comprehensive Trend Analysis Report
Cerner Corporation (NASDAQ:CERN) is currently trading 1.68% below its 52-week-high, 44.74% above its 52-week-low. The 1-year range for the stock is $48.39 – $71.24. Cerner Corporation (CERN) has a price to earnings ratio of 47.32 versus Nasdaq average of 18.01. The stock price has outperformed the Nasdaq by 6.2%. CERN is currently valued at $24 billion and closed the last trading session at $70.98. The stock has a 50-day moving average of $66.27 and a 200-day moving average of $61.57.
CERN reported last quarter earnings on Tuesday, February 10. The Health Care Technology company announced earning per share of $0.44 against a consensus Street estimate of $0.43, beating the average estimate by $0.01. This corresponds to an increase of $0.1 compared to the same quarter of the previous fiscal year.
Cerner Corporation (CERN) current short interest stands at 13.92 millions shares. It has decreased by 1% from the same period of last month. Around 5% of the company’s shares, which are float, are short sold. With a 10-days average volume of 2.14 millions shares, the number of days required to cover the short positions stand at 6.5 days.
Is this a Buying Opportunity? Click here for a free Trend Analysis Report
There are currently twenty-nine analysts that cover CERN. Of those twenty-nine, twenty-four have a Buy rating, four have a Hold rating and one has a Sell rating. On a consensus basis this yields to a Overweight rating. The consensus target price stands at $73.06.
A recent analyst activity consisted of RBC Capital Mkts reiterating their Outperform stance on February 11. RBC Capital Mkts decreased price target from $75 to $70. This corresponds to a 1.38% downside from the last closing price. On the date of report, the stock closed at $67.71.
Oppenheimer reiterated their Underperform stance on the same day, and increased their price target on CERN from $37 to $41. This corresponds to a 42.24% downside from the last closing price.
A third research firm was FBR Capital who reiterated their Outperform stance on October 24. FBR Capital increased their price target on Cerner from $67 to $70. This translates to a 1.38% downside from the last closing price. On the date of report, the stock closed at $61.12.
Cerner Corporation is a worldwide supplier of healthcare solutions and services. The Company’s Solutions are designed to optimize clinical and financial outcomes for healthcare organizations ranging from single-doctor practices, to health systems, to entire countries, for the pharmaceutical and medical device industries, and for the healthcare commerce system.
